These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 16634706)

  • 21. New developments in management of oral mucositis in patients with head and neck cancer or receiving targeted anticancer therapies.
    Li E; Trovato JA
    Am J Health Syst Pharm; 2012 Jun; 69(12):1031-7. PubMed ID: 22644979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interventions for preventing oral mucositis for patients with cancer receiving treatment.
    Worthington HV; Clarkson JE; Eden OB
    Cochrane Database Syst Rev; 2006 Apr; (2):CD000978. PubMed ID: 16625538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral mucositis.
    Raber-Durlacher JE; Elad S; Barasch A
    Oral Oncol; 2010 Jun; 46(6):452-6. PubMed ID: 20403721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Professional oral health care reduces oral mucositis pain in patients treated by superselective intra-arterial chemotherapy concurrent with radiotherapy for oral cancer.
    Kubota K; Kobayashi W; Sakaki H; Nakagawa H; Kon T; Mimura M; Ito R; Furudate K; Kimura H
    Support Care Cancer; 2015 Nov; 23(11):3323-9. PubMed ID: 25987235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of salivary function in modulating chemotherapy-induced oropharyngeal mucositis: a review of the literature.
    Epstein JB; Tsang AH; Warkentin D; Ship JA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Jul; 94(1):39-44. PubMed ID: 12193891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses.
    Stokman MA; Spijkervet FK; Boezen HM; Schouten JP; Roodenburg JL; de Vries EG
    J Dent Res; 2006 Aug; 85(8):690-700. PubMed ID: 16861284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Palifermin: new drug. Prevention of oral mucositis: inappropriate evaluation.
    Prescrire Int; 2007 Aug; 16(90):135-8. PubMed ID: 17724832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention and treatment of regimen-related mucosal toxicity.
    Bowen JM
    Recent Pat Anticancer Drug Discov; 2008 Jun; 3(2):68-75. PubMed ID: 18537748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural Products for Management of Oral Mucositis Induced by Radiotherapy and Chemotherapy.
    Aghamohamamdi A; Hosseinimehr SJ
    Integr Cancer Ther; 2016 Mar; 15(1):60-8. PubMed ID: 26306626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention and treatment of oropharyngeal mucositis following cancer therapy: are there new approaches?
    Kwong KK
    Cancer Nurs; 2004; 27(3):183-205. PubMed ID: 15238805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interventions for preventing oral mucositis for patients with cancer receiving treatment.
    Clarkson JE; Worthington HV; Eden OB
    Cochrane Database Syst Rev; 2003; (3):CD000978. PubMed ID: 12917895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucositis: Its Occurrence, Consequences, and Treatment in the Oncology Setting.
    Pico JL; Avila-Garavito A; Naccache P
    Oncologist; 1998; 3(6):446-451. PubMed ID: 10388137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic evaluation of palifermin for mucosal protection from chemotherapy and radiation.
    Weigelt C; Haas R; Kobbe G
    Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):505-15. PubMed ID: 21417820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amifostine in the management of radiation-induced and chemo-induced mucositis.
    Bensadoun RJ; Schubert MM; Lalla RV; Keefe D
    Support Care Cancer; 2006 Jun; 14(6):566-72. PubMed ID: 16586122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral mucositis.
    Scully C; Sonis S; Diz PD
    Oral Dis; 2006 May; 12(3):229-41. PubMed ID: 16700732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological modulation of radiation-induced oral mucosal complications.
    Bockel S; Vallard A; Lévy A; François S; Bourdis M; Le Gallic C; Riccobono D; Annede P; Drouet M; Tao Y; Blanchard P; Deutsch É; Magné N; Chargari C
    Cancer Radiother; 2018 Sep; 22(5):429-437. PubMed ID: 29776830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of oral mucositis or oral candidiasis for patients with cancer receiving chemotherapy (excluding head and neck cancer).
    Clarkson JE; Worthington HV; Eden OB
    Cochrane Database Syst Rev; 2000; (2):CD000978. PubMed ID: 10796567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.
    Veness MJ; Foroudi F; Gebski V; Timms I; Sathiyaseelan Y; Cakir B; Tiver KW
    Australas Radiol; 2006 Oct; 50(5):468-74. PubMed ID: 16981945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of oral mucositis in patients who have cancer.
    Lalla RV; Sonis ST; Peterson DE
    Dent Clin North Am; 2008 Jan; 52(1):61-77, viii. PubMed ID: 18154865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer therapy-related oral mucositis.
    Redding SW
    J Dent Educ; 2005 Aug; 69(8):919-29. PubMed ID: 16081575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.